ARCHIVES

The Antineoplaston Anomaly: How A Drug Was Used For Decades In Thousands Of Patients, With No Safety, Efficacy Data

This article is from The Cancer Letter archive.

Vol. 24 No. 36 | September 25, 1998

Download PDF Visit The Full Archive

Related Articles

False-Positive Mammograms Can Indicate Higher Cancer Risk

April 27, 2012

More money would speed progress, NCI says, but backs off previous commitment to meet 2015 goal by 2010.

July 29, 2005

NCAB, President’s Cancer Panel honor the late Paul Calabresi.

June 11, 2004

White House Appoints Slamon To Cancer Panel; Brinker To Address Republican Convention.

July 28, 2000

Carfilzomib Demonstrates Clinical Benefit Rate of 64%

December 30, 2011

Abraxane and Gemcitabine Improves Overall Survival

November 30, 2012